Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer
Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer. // Radiotherapy & Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0167814026045408?dgcid=rss_sd_all
Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer. Radiotherapy & Oncology. https://www.sciencedirect.com/science/article/pii/S0167814026045408?dgcid=rss_sd_all
“Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer.” Radiotherapy & Oncology.
@article{article95070,
title = {Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer},
journal = {Radiotherapy \& Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0167814026045408?dgcid=rss_sd_all}
}